Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

DiFrancesco

Showing results (501-510 of 544) with videos related to

Pageof 55
Sort By:
Clinical Kidney Journal|September 4, 2023
Associations between eGFR and albuminuria with right ventricular measures: the MESA-Right Ventricle studyFaeq Husain-Syed, Matthew F DiFrancesco, Rajat Deo, et al.
Epilepsia|July 26, 2021
Comorbidities in patients with epilepsy: Frequency, mechanisms and effects on long-term outcomeGiorgia Giussani, Elisa Bianchi, Simone Beretta, et al.
BMJ Open|March 9, 2026
MULTIsite feasibility of MUSIc therapy to address Quality Of Life in Sickle cell disease (MULTI-MUSIQOLS): protocol for a mixed-methods randomised controlled trial at two US medical centresSamuel N Rodgers-Melnick, Viraj Gorthi, Angelique Foss, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|August 26, 2025
Pulmonary vascular morphology in cystic fibrosisQiwei Xiao, Goutham Mylavarapu, James F Chmiel, et al.
The Lancet. Respiratory Medicine|October 3, 2025
Taladegib for the treatment of idiopathic pulmonary fibrosis (ENV-IPF-101): a multicentre, randomised, double-blind, placebo-controlled, phase 2a trialT M Maher, J G Goldin, J Hood, et al.
Microbiology Spectrum|April 26, 2023
Small Molecule Inhibition of an Exopolysaccharide Modification Enzyme is a Viable Strategy To Block Pseudomonas aeruginosa Pel Biofilm FormationErum Razvi, Benjamin R DiFrancesco, Gregory A Wasney, et al.
Nature Communications|September 30, 2025
Graphene oxide increases the phototransduction efficiency of copolymeric nanoimplants and rescues visual functions in rat and pig models of Retinitis pigmentosaF Galluzzi, S Francia, S Cupini, et al.
Annals of Neurology|April 30, 2013
Anti-amyloid β autoantibodies in cerebral amyloid angiopathy-related inflammation: implications for amyloid-modifying therapiesFabrizio Piazza, Steven M Greenberg, Mario Savoiardo, et al.
Pharmacological Research|September 17, 2020
Gabapentin treatment in a patient with KCNQ2 developmental epileptic encephalopathyMaria Virginia Soldovieri, Elena Freri, Paolo Ambrosino, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|August 17, 2018
Early Treatment with Quinidine in 2 Patients with Epilepsy of Infancy with Migrating Focal Seizures (EIMFS) Due to Gain-of-Function KCNT1 Mutations: Functional Studies, Clinical Responses, and Critical Issues for Personalized TherapyRobertino Dilena, Jacopo C DiFrancesco, Maria Virginia Soldovieri, et al.
Pageof 55

Showing results (501-510 of 544) with videos related to

Sort By:
Pageof 55
Clinical Kidney Journal|September 4, 2023
Associations between eGFR and albuminuria with right ventricular measures: the MESA-Right Ventricle studyFaeq Husain-Syed, Matthew F DiFrancesco, Rajat Deo, et al.
Epilepsia|July 26, 2021
Comorbidities in patients with epilepsy: Frequency, mechanisms and effects on long-term outcomeGiorgia Giussani, Elisa Bianchi, Simone Beretta, et al.
BMJ Open|March 9, 2026
MULTIsite feasibility of MUSIc therapy to address Quality Of Life in Sickle cell disease (MULTI-MUSIQOLS): protocol for a mixed-methods randomised controlled trial at two US medical centresSamuel N Rodgers-Melnick, Viraj Gorthi, Angelique Foss, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|August 26, 2025
Pulmonary vascular morphology in cystic fibrosisQiwei Xiao, Goutham Mylavarapu, James F Chmiel, et al.
The Lancet. Respiratory Medicine|October 3, 2025
Taladegib for the treatment of idiopathic pulmonary fibrosis (ENV-IPF-101): a multicentre, randomised, double-blind, placebo-controlled, phase 2a trialT M Maher, J G Goldin, J Hood, et al.
Microbiology Spectrum|April 26, 2023
Small Molecule Inhibition of an Exopolysaccharide Modification Enzyme is a Viable Strategy To Block Pseudomonas aeruginosa Pel Biofilm FormationErum Razvi, Benjamin R DiFrancesco, Gregory A Wasney, et al.
Nature Communications|September 30, 2025
Graphene oxide increases the phototransduction efficiency of copolymeric nanoimplants and rescues visual functions in rat and pig models of Retinitis pigmentosaF Galluzzi, S Francia, S Cupini, et al.
Annals of Neurology|April 30, 2013
Anti-amyloid β autoantibodies in cerebral amyloid angiopathy-related inflammation: implications for amyloid-modifying therapiesFabrizio Piazza, Steven M Greenberg, Mario Savoiardo, et al.
Pharmacological Research|September 17, 2020
Gabapentin treatment in a patient with KCNQ2 developmental epileptic encephalopathyMaria Virginia Soldovieri, Elena Freri, Paolo Ambrosino, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|August 17, 2018
Early Treatment with Quinidine in 2 Patients with Epilepsy of Infancy with Migrating Focal Seizures (EIMFS) Due to Gain-of-Function KCNT1 Mutations: Functional Studies, Clinical Responses, and Critical Issues for Personalized TherapyRobertino Dilena, Jacopo C DiFrancesco, Maria Virginia Soldovieri, et al.
Pageof 55